Clinical Edge Journal Scan

Complications and outcomes of different management pathways of CRC and synchronous liver metastases


 

Key clinical point: Management of colorectal cancer ( CRC) and synchronous liver metastases with staged liver-first or bowel-first routes or synchronous combined liver and bowel surgery, all with contemporary systemic chemotherapy, led to similar perioperative complications and oncological outcomes.

Major finding: Postoperative complications ( P = .66), total critical care occupancy ( P = .92) and mean total inpatient stay ( P = .91) were similar between synchronous and staged management pathways. Overall, 35% of patients were disease-free at 12 months, with no difference between groups ( P = .448).

Study details: Findings are from CoSMIC, a prospective inception cohort study including 125 patients with CRC and synchronous liver metastases.

Disclosures: AKC Chan was supported by a grant from the Dickinson Trust.

Source: Chan AKC et al. Ann Surg Oncol. 2021 Oct 30. doi: 10.1245/s10434-021-11017-7 .

Recommended Reading

Vitamin D status may play a pivotal role in colon cancer prevention
MDedge Hematology and Oncology
Tracking adenomas per colonoscopy shows promise as quality measure
MDedge Hematology and Oncology
Balloon-enhanced colonoscopy finds more adenomas
MDedge Hematology and Oncology
Dogs show potential as medical detectives in breast cancer
MDedge Hematology and Oncology
Severe COVID two times higher for cancer patients
MDedge Hematology and Oncology
A single flexible sigmoidoscopy shows strong protective effect for CRC incidence and mortality
MDedge Hematology and Oncology
Simultaneous colectomy and HAIP placement safe in liver metastases of colon carcinoma
MDedge Hematology and Oncology
Young age tied with higher risk for relapse in high-risk stage III CRC
MDedge Hematology and Oncology
Higher intake of preserved vegetables and colorectal polyps: What is the link?
MDedge Hematology and Oncology
Preoperative SCRT with subsequent CAPOX and camrelizumab shows promise in locally advanced rectal cancer
MDedge Hematology and Oncology